CapsoVision, Inc. Common Stock (NASDAQ:CV) — Market Cap & Net Worth
Market Cap & Net Worth: CapsoVision, Inc. Common Stock (CV)
CapsoVision, Inc. Common Stock (NASDAQ:CV) has a market capitalization of $324.02 Million ($324.02 Million) as of June 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14542 globally and #3403 in its home market, demonstrating a -13.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CapsoVision, Inc. Common Stock's stock price $6.50 by its total outstanding shares 49849728 (49.85 Million). Review CV total liabilities to assess the company's total debt and financial obligations.
CapsoVision, Inc. Common Stock Market Cap History: 2025 to 2026
CapsoVision, Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $532.89 Million to $324.02 Million (0.00% CAGR).
CapsoVision, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CapsoVision, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
39.32x
CapsoVision, Inc. Common Stock's market cap is 39.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $532.89 Million | $13.55 Million | -$25.32 Million | 39.32x | N/A |
Competitor Companies of CV by Market Capitalization
Companies near CapsoVision, Inc. Common Stock in the global market cap rankings as of June 19, 2026.
Key companies related to CapsoVision, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
CapsoVision, Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, CapsoVision, Inc. Common Stock's market cap moved from $532.89 Million to $ 324.02 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $324.02 Million | -39.20% |
| 2025 | $532.89 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of CapsoVision, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $324.02 Million USD |
| MoneyControl | $324.02 Million USD |
| MarketWatch | $324.02 Million USD |
| marketcap.company | $324.02 Million USD |
| Reuters | $324.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more